Integrative analysis of ferroptosis regulators for clinical prognosis based on deep learning and potential chemotherapy sensitivity of prostate cancer.
deep learning
drug sensitivity
ferroptosis
prognosis
prostate cancer
Journal
Precision clinical medicine
ISSN: 2516-1571
Titre abrégé: Precis Clin Med
Pays: England
ID NLM: 101739592
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
16
12
2022
accepted:
31
01
2023
entrez:
6
3
2023
pubmed:
7
3
2023
medline:
7
3
2023
Statut:
epublish
Résumé
Exploring useful prognostic markers and developing a robust prognostic model for patients with prostate cancer are crucial for clinical practice. We applied a deep learning algorithm to construct a prognostic model and proposed the deep learning-based ferroptosis score (DLF
Identifiants
pubmed: 36874167
doi: 10.1093/pcmedi/pbad001
pii: pbad001
pmc: PMC9982702
doi:
Types de publication
Journal Article
Langues
eng
Pagination
pbad001Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the West China School of Medicine & West China Hospital of Sichuan University.
Références
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
J Clin Oncol. 2013 May 10;31(14):1748-57
pubmed: 23569316
Nat Rev Urol. 2019 May;16(5):281-290
pubmed: 30808988
Genes (Basel). 2022 Mar 30;13(4):
pubmed: 35456426
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
World J Urol. 2021 May;39(5):1387-1403
pubmed: 33106940
Front Cell Dev Biol. 2022 Jan 06;9:774625
pubmed: 35071228
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Proc Natl Acad Sci U S A. 2020 Dec 8;117(49):31189-31197
pubmed: 33229547
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Front Immunol. 2022 Feb 07;13:798471
pubmed: 35197975
Cell Res. 2020 Feb;30(2):146-162
pubmed: 31949285
Int J Biol Sci. 2022 Jan 1;18(1):180-198
pubmed: 34975326
Lancet. 2021 Sep 18;398(10305):1075-1090
pubmed: 34370973
J Comput Aided Mol Des. 2010 May;24(5):417-22
pubmed: 20401516
Cancers (Basel). 2020 Jul 28;12(8):
pubmed: 32731472
Cancer Res. 2021 Mar 15;81(6):1583-1594
pubmed: 33483372
Nat Rev Dis Primers. 2021 Feb 4;7(1):9
pubmed: 33542230
Nat Rev Urol. 2018 Jan;15(1):11-24
pubmed: 29089606
Front Oncol. 2021 Jul 15;11:623313
pubmed: 34336641
BMC Cancer. 2022 Jan 3;22(1):1
pubmed: 34979993
Cell Death Dis. 2014 Oct 02;5:e1437
pubmed: 25275598
Eur Urol. 2018 Apr;73(4):572-582
pubmed: 29129398
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Biometrics. 1988 Sep;44(3):837-45
pubmed: 3203132
Cancer Res. 2015 Apr 1;75(7):1413-22
pubmed: 25649766
Int J Biol Sci. 2020 Jul 6;16(13):2430-2441
pubmed: 32760210
Cancer Res. 2011 Jul 1;71(13):4573-84
pubmed: 21602434
Lancet. 2018 Nov 10;392(10159):2052-2090
pubmed: 30340847
Cancer Res. 2014 Jun 15;74(12):3228-37
pubmed: 24713434